HDL-C promotes cholesterol accumulation in tumor cell membranes, enhancing epidermal growth factor receptor (EGFR) signaling—an effect more commonly seen in adenocarcinomas in the lower lobes (31, 32). Here, EGFR is linked to neoplasm.